PS01 PRESIDENTIAL SYMPOSIUM SATURDAY, JANUARY 30, 2021 - 07:00-09:00
PS01.05 Surgical and Clinical Outcomes With Neoadjuvant Atezolizumab in Resectable Stage IB–IIIB NSCLC: LCMC3 Trial Primary Analysis

https://doi.org/10.1016/j.jtho.2021.01.320Get rights and content
Under an Elsevier user license
open archive

Cited by (0)